(NYSE: PRGO) Perrigo Co's forecast annual revenue growth rate of 0.61% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 132.8%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.67%.
Perrigo Co's revenue in 2025 is $4,281,800,000.On average, 6 Wall Street analysts forecast PRGO's revenue for 2025 to be $596,187,206,988, with the lowest PRGO revenue forecast at $572,103,005,413, and the highest PRGO revenue forecast at $614,628,824,194. On average, 6 Wall Street analysts forecast PRGO's revenue for 2026 to be $592,884,230,772, with the lowest PRGO revenue forecast at $568,111,909,152, and the highest PRGO revenue forecast at $613,252,584,104.
In 2027, PRGO is forecast to generate $602,242,663,384 in revenue, with the lowest revenue forecast at $569,763,397,260 and the highest revenue forecast at $627,427,857,031.